Title:
VEGF受容体融合タンパク質およびそれらの使用
Document Type and Number:
Japanese Patent JP2009531036
Kind Code:
A
Abstract:
Vascular endothelial growth factor (VEGF) receptor fusion protein comprising Ig domain 2 of Flt-1 and Ig domains 3, or Ig domain 2 of Flt-1 and Ig domain 3 and 4 of KDR, the gene encoding the fusion protein, the pharmaceutical composition containing the fusion protein and the pharmaceutical use of the fusion protein are provided. The fusion protein can be used for treatment of eye disorders involving angiogenesis such as diabetic retinopathy.
Inventors:
You, Dechao, Michael
Application Number:
JP2009501824A
Publication Date:
September 03, 2009
Filing Date:
March 29, 2007
Export Citation:
Assignee:
Zendu Kang Hong Biotechnology Company Limited
International Classes:
C12N15/09; A61K38/00; A61K47/10; A61K47/26; A61K47/34; A61P27/02; C07K14/71; C07K19/00; C12P21/02; A61P9/00
Foreign References:
| CN1706867A | 2005-12-14 | |||
| WO2005121176A1 | 2005-12-22 | |||
| WO2005000895A2 | 2005-01-06 |
Attorney, Agent or Firm:
Kenzo Hara International Patent Office